CARL L GORDON Insider Trading $NTLA Intellia Therapeutics, Inc.
Get free email notifications about insider trading for CARL L GORDON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARL L GORDON. CARL L GORDON is Director in SELECTA BIOSCIENCES INC ($SELB) and Director in Arsanis, Inc. ($ASNS) and Director in Turning Point Therapeutics, Inc. ($TPTX) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in Alector, Inc. ($ALEC) and Director in Keros Therapeutics, Inc. ($KROS) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in Adicet Bio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Terns Pharmaceuticals, Inc. ($TERN).
CARL L GORDON in Intellia Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of CARL L GORDON: Director
Holdings: 2,662,180 shares
Current Value: $35,406,994
Latest Transaction: May 19 2017
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CARL L GORDON in Intellia Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TORC, ALEC, ARMO, NTLA, KROS, KNTE, ORIC, PRVL, SELB, TERN, TPTX, ASNS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2017 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Option Exercise | A | 14.35 | 19,000 | 272,650 | 19,000 | |
| May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 873,475 | 0 | 0 | |
| May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 2,857,143 | 0 | 0 | |
| May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Buy | P | 18.00 | 58,534 | 1,053,612 | 2,662,180 | 2.6 M to 2.7 M (+2.25 %) |
| May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Buy | P | 18.00 | 191,466 | 3,446,388 | 2,603,646 | 2.4 M to 2.6 M (+7.94 %) |
| May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Buy | C | 0.00 | 564,780 | 0 | 2,412,180 | 1.8 M to 2.4 M (+30.57 %) |
| May 11 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Buy | C | 0.00 | 1,847,400 | 0 | 1,847,400 | 0 to 1.8 M |
| May 09 2016 | NTLA | Intellia Therapeut ... | GORDON CARL L | Director | Option Exercise | A | 18.00 | 23,529 | 423,522 | 23,529 |
Page: 1